Length of stay is a crucial metric in healthcare management, reflecting the duration a patient occupies a hospital bed. According to the Kenya National Commission of Human Rights, around 25% of ...
An open-label non–HLA-A*02 cohort showed a 0.7% annualized recurrence rate after primary immunization with GLSI-100, measured over an average 1.2 patient-years of exposure. Historical comparison to ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase ...
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company focused on developing ...
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01 ...
HIV-positive status may be associated with increased risks for complications and poor postoperative total joint arthroplasty ...
The 2026 European Association of Urology (EAU) annual meeting featured an advancement in metastatic castration resistant ...
Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for risk stratification remain elusive. This study sought to explore the ...
A study published in BMC Infectious Diseases has found that older patients with sepsis have lower 28-day mortality when blood pressure is maintained within an optimal range. Current ...
Durable 76% complete response (CR) rate at 12 months with 95% CR rate at any time in high-risk NMIBCBCG-unresponsive patients achieved an 80% CR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results